Sugammadex is an octasaccharide derivative used for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. The encapsulation by sugammadex blocks the ability of the neuromuscular blocking agents to bind to nicotinic receptors in the neuromuscular junction and thereby reverses the induced neuromuscular blockade.


Product Name Sugammadex
CAS Number 343306-79-6
Therapeutic Class Nondepolarizing Muscle Relaxant Antagonist
Dosage Form Solution for injection
Availability Development Completed
Regulatory Status USDMF
Similar Products